SpyGlass Pharma, Inc.

Analyst research, target price, syndicate analytics, and valuation sections are included with an active subscription. View plans

Symbol

SGP

Event Date

2026-02-06

Sector

Health Care

Subsector

Health Care Equipment & Supplies

Offer Range

—

Shares Offered

116.62M

Shares Outstanding Pre-IPO

129.2M

Total Shares Post-IPO

129.2M

Market Cap

—

Target Price

$00.00

Implied Upside vs Midpoint

$00.00

Description

—

Post-IPO economic shares by class.

Class	Shares	% Economic
Common Stock (listed) 1 vote per share (standard)	12.58M	9.7%
Series A Preferred Stock Votes as converted into Common Stock (per terms) · convertible into Common Stock at original issue price ($1.10 per share basis)	5.48M	4.2%
Series B Preferred Stock Votes as converted into Common Stock · convertible at $1.29 per share basis	21.32M	16.5%
Series C‑1 Preferred Stock Votes as converted into Common Stock; Series C holders elect specified directors · convertible at $1.41 per share basis	28.29M	21.9%
Series C‑2 Preferred Stock Votes as converted into Common Stock · convertible at $1.77 per share basis	28.28M	21.9%
Series D Preferred Stock Votes as converted into Common Stock	33.25M	25.7%
Total economic shares	129.2M	100%

████████████████████